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ABSTRACT
Background: Several studies were performed to define predic-
tors of adverse events after percutaneous coronary intervention 
(PCI). Patients whose post-procedure myocardial fractional flow 
of reserve (FFR) is < 0.90 have an incidence of major cardiac 
events at 6 months at least 3 times higher than those whose 
FFR is ≥ 0.90. The aim of this study was to identify clinical, 
angiographic and procedure-related factors associated with a 
post-PCI FFR < 0.90. Methods: One hundred and ninety-three 
patients (256 lesions) treated between 2004 and 2005 were 
included, and FFR was measured before and after PCI in all 
of the treated vessels. Patients were divided into groups with 
FFR < 0.90 and FFR ≥ 0.90. Logistic regression multivariate 
analysis was used to determine the adjusted odds ratio (OR). 
Results: FFR was measured in all lesions. No difference was 
observed in clinical parameters between groups. There were 
differences in angiographic and procedure-related parameters, 
however, when the logistic regression model was used, the 
only variable associated to post-PCI FFR < 0.90 was the treat-
ment of the left anterior descending artery (OR, 12.1; 95% 
CI, 6.4-22.9; P  < 0.01). Conclusions: The only predictor of 
a FFR < 0.90 after PCI was the treatment of the left anterior 
descending artery.
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RESUMO
Utilização do Fluxo Fracionado de Reserva  
do Miocárdio para Identificar Variáveis Preditoras de Pior 
Prognóstico Após Intervenções Coronárias Percutâneas
Introdução: Vários estudos foram realizados para definir predi-
tores de eventos adversos pós-intervenção coronária percutânea 
(ICP). Pacientes cujo fluxo fracionado de reserva do miocárdio 
(FFR) pós-procedimento é < 0,90 apresentam índice de eventos 
cardíacos adversos maiores em 6 meses pelo menos 3 vezes maior 
do que aqueles cujo FFR é ≥ 0,90. Este estudo teve por objetivo 
identificar fatores clínicos, angiográficos e do procedimento as-
sociados à FFR pós-ICP < 0,90. Métodos: Foram incluídos 193 
pacientes (256 lesões) tratados entre 2004 e 2005, e o FFR foi 
medido antes e depois da ICP em todos os vasos tratados. Os 
pacientes foram divididos nos grupos FFR < 0,90 e FFR ≥ 0,90. 
Análise multivariada por regressão logística foi utilizada para 
determinar as razões de chances (odds ratio − OR) ajustadas. 
Resultados: Foi possível obter o FFR em todas as lesões. Não se 
observou diferença nos parâmetros clínicos entre os dois grupos 
de pacientes. Houve diferença em alguns parâmetros angiográ-
ficos e do procedimento, porém, ao aplicarmos o modelo de 
regressão logística, a única variável que se associou com FFR 
pós-ICP < 0,90 foi o tratamento da artéria descendente anterior 
(OR = 12,1; IC 95% 6,4-22,9; P < 0,01). Conclusões: A única 
variável preditora de FFR pós-ICP < 0,90 foi o tratamento da 
artéria descendente anterior.
DESCRITORES: Intervenção coronária percutânea. Stents. 
Circulação coronária. Estenose coronária.
I t is known that the most important prognostic factor in patients with coronary artery disease (CAD) is the presence of myocardial ischemia.1,2 Conversely, the 
value of the myocardial fractional flow reserve (FFR) 
in myocardial ischemia detection has been broadly 
established.3-5 Vessels with FFR ≥ 0.80 can be safely 
treated conservatively, while FFR < 0.80 is a signal of 
myocardial ischemia and thus, sometimes percutaneous 
or surgical revascularization is indicated.6-9
A multicenter registry published in 2002 showed 
that the post-percutaneous coronary intervention (PCI) 
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Statistical Analysis
All variables were tested for normality by the 
Shapiro-Wilks and/or Kolmogorov-Smirnov test. In the 
descriptive analysis, numerical variables were shown as 
mean ± standard deviation or median and interquartile 
range [IQ], and categorical variables as numbers (n) 
and percentages (%). Chi-squared or Fisher’s exact 
tests were used for categorical variables; the unpaired 
Student’s t-test and Wilcoxon-Mann-Whitney test were 
used for continuous variables. All variables with sig-
nificant difference between the groups (P < 0.05) were 
used for the multivariate logistic regression analysis to 
determine independent predictors of FFR < 0.90 after 
the procedure. Statistical analysis was performed using 
the R software, release 3.0.1 (R Core Team – Vienna, 
Austria). P-values < 0.05 were considered statistically 
significant, and all tests were two-tailed.
RESULTS
For seven consecutive months, 284 patients were 
admitted to the service to undergo PCI with or without 
stenting. Of these, nine had myocardial infarction, 25 
had chronic occlusion of culprit vessel, and 57 had 
lesions whose pre-PCI FFR was > 0.75 and thus, were 
excluded from this analysis. Therefore, 193 patients 
(256 lesions) were included in this study. Diagnostic 
coronary angiography had been performed in all patients 
two days to three weeks before. The clinical character-
istics of these patients are shown in Table 1. The mean 
age was 61.6 ± 10.5 years, 34.7 % were females, and 
24.4 % were diabetics. Most patients had stable angina 
(71.5%), multivessel disease (71%), and preserved left 
ventricular ejection fraction (59 ± 15%). No statistically 
significant differences were observed between the clini-
cal characteristics of two groups analyzed.
FFR measurement was successfully obtained in all 
analyzed lesions. PCI with stenting was performed in 
238 stenoses of 179 patients, with 100% of procedural 
success. In 18 stenoses (14 patients), PCI was performed 
with a balloon catheter, also with angiographic and 
clinical success in all cases. 
Angiographic and procedural characteristics of 
the studied lesions
The angiographic characteristics of the lesions are 
shown in Table 2. The left anterior descending (LAD) 
artery was the most often treated vessel in the group 
with FFR < 0.90. The patients in this group had smaller 
reference vessel diameters (2.61 [2.29 to 2.93] mm vs. 
2.84 [2.49 to 3.11] mm, P < 0.01), larger pre minimum 
luminal diameters (0.89 [0.7 to 1.14] mm vs. 0.80 
[0.63 to 1] mm, P = 0.02) and the same extent of 
lesion (14.0 [9.7 to 20.1] mm vs. 15.1 [10.3 to 20.2] 
mm, P = 0.41).
value of FFR has important prognostic implications.10 
Patients who’s post-procedure FFR was < 0.90 showed an 
at least three-fold higher rate of major adverse cardiac 
events after six months than those with FFR ≥ 0.90.
The aim of this study was to analyze the predictive 
variables of a post-procedure FFR < 0.90 in patients 
undergoing PCI in an interventional cardiology service, 
thus identifying factors that could lead to an unfavorable 
clinical outcome at the long-term follow up.
METHODS
The study sample consisted of patients referred to 
the Interventional Cardiology Service of Clínica Santa 
Helena, Cabo Frio, RJ, Brazil, from October 2004 to 
April 2005, for elective PCI. Patients with chronic vessel 
occlusion or left main coronary artery lesion ≥ 50% 
were excluded from the analysis.
Cardiac catheterization and intracoronary blood 
pressure measures
Catheterization was performed via femoral artery, 
using 6F or 7F guide catheters with no side holes. 
Before the angiography, 10,000 IU of intravenous 
heparin and 0.5 mg of nitroglycerin were administered 
via intracoronary route. Subsequently, intracoronary 
pressure measurements were performed in all ves-
sels with stenosis ≥  50% by visual estimation, using 
a 0.014” guide wire (PressureWire® 4 Sensor; RADI 
Medical Systems – Uppsala, Sweden) placed on the 
distal bed of each coronary to be analyzed, one at a 
time.11 Intravenous adenosine was administered through 
a sheath placed in the femoral vein, at a dose of 140 
mg/kg/min, in order to induce maximal hyperemia. FFR 
was automatically determined as the ratio between the 
mean distal coronary pressure and mean aortic pres-
sure, measured by the guide catheter during maximal 
hyperemia.3 All stenoses responsible for ischemia (FFR 
< 0.75 cutoff value used before the FAME study) were 
treated by PCI, when technically possible. After the 
procedure, FFR was measured again, and lesions and 
patients were divided into two groups: FFR ≥ 0.90 (85 
patients/107 lesions) and FFR < 0.90 (108 patients/149 
lesions). In cases where the patient had more of one 
treated lesion, and one of them showed post-procedure 
FFR < 0.90 and the other(s) FFR ≥ 0.90, the patient 
was allocated to the FFR < 0.90 group. 
Quantitative coronary angiography
Quantitative coronary angiography was performed 
offline, considering the projection according to which 
it would be possible to demonstrate more severe le-
sion, using a software with automatic contour detection 
algorithm (CAAS II – Pie Medical Imaging; Maastricht, 
the Netherlands), as previously described.12 
Brito et al. 
Using FFR Post-PCI
Rev Bras Cardiol Invasiva. 
2013;21(4):367-72
369
TABLE 1 
Baseline clinical characteristics
Clinical characteristics
Groups
P-value
Patients
(n = 193)
Post-PCI FFR < 0.90
(n = 108)
Post-PCI FFR ≥ 0.90
(n = 85)
Age, years 61.6 ± 10.5 60.8 ± 10 62.6 ± 11.1 0.24
Female gender 67 (34.7) 33 (30.6) 34 (40.0) 0.22
Symptoms, n (%) 0.30
Stable angina 138 (71.5) 82 (75.9) 56 (65.9)
Silent ischemia 39 (20.2) 19 (17.6) 20 (23.5)
Unstable angina 16 (8.3) 7 (6.5) 9 (10.6)
Risk factors, n (%)
Arterial hypertension 162 (83.9) 90 (83.3) 72 (84.7) 0.85
Dyslipidemia 90 (46.6) 52 (48.1) 38 (44.7) 0.66
FH of CAD 74 (38.3) 47 (43.5) 27 (31.8) 0.10
Diabetes 47 (24.4) 27 (25) 20 (23.5) 0.87
Smoking 43 (22.3) 24 (22.2) 19 (22.4) > 0.99
Previous AMI, n (%) 92 (47.7) 50 (46.3) 42 (49.4) 0.77
Previous PCI, n (%) 31 (16.1) 19 (17.6) 12 (14.1) 0.56
Previous CABG, n (%) 6 (3.1) 4 (4.7) 2 (1.9) 0.41
LVEF, n (%) 59 ± 15 56.9 ± 15.3 60.7 ± 14.6 0.08
Multivessel disease, n (%) 137 (71) 79 (73.1) 58 (68.2) 0.52
FFR = fractional flow reserve of the myocardium; PCI = percutaneous coronary intervention; FH-CAD = family history of coronary artery 
disease; AMI = acute myocardial infarction; CABG = coronary artery bypass graft surgery; LVEF = left ventricular ejection fraction.
TABLE 2  
Angiographic and procedure characteristics (analysis by lesion)
Clinical characteristics
Groups
P-value
Lesions
(n = 256)
Post-PCI FFR < 0.90
(n = 149)
Post-PCI FFR ≥ 0.90
(n = 107)
Coronary artery, n (%) < 0.01
Left descending artery 140 (54.7) 117 (78.5) 23 (21.5)
Right coronary artery 61 (23.8) 13 (8.7) 48 (44.9)
Left circumflex artery 55 (21.5) 19 (12.8) 36 (33.6)
ACC/AHA B2 or C, n (%) 127 (49.6) 69 (46.3) 58 (54.2) 0.25
Calcified lesions, n (%) 117 (45.7) 75 (50.3) 42 (39.3) 0.10
Number of stents per lesion 1.02 ± 0.39 0.97 ± 0.43 1.08 ± 0.34 0.02
Mean stent diameter, median [IQ], mm 3 [2.5-3.5] 2.75 [2.5-3] 3.0 [2.75-3.5] < 0.01
Pre-RD, median [IQ], mm 2.7 [2.35-2.99] 2.61 [2.29-2.93] 2.84 [2.49-3.11] < 0.01
Pre-MLD, median [IQ], mm 0.83 [0.66-1.10] 0.89 [0.7-1.14] 0.80 [0.63-1] 0.02
Pre-stenosis diameter, median [IQ], mm 68 [60-75] 66 [58-73] 70 [64.5-78] < 0.01
Lesion extension, median [IQ], mm 14.5 [10.1-20.2] 14.0 [9.7-20.1] 15.1 [10.3-20.2] 0.41
Pre-FFR, median [IQ], mm 0.60 [0.47-0.69] 0.61 [0.49-0.69] 0.57 [0.46-0.69] 0.63
Post-RD, mm 3.0 ± 0.49 2.9 ± 0.50 3.14 ± 0.46 < 0.01
Post-MLD, mm 2.63 ± 0.50 2.52 ± 0.52 2.78 ± 0.43 < 0.01
Post-stenosis diameter, median [IQ], mm 12 [9-16] 12 [8-14.5] 12 [9-16] 0.10
Post-PCI FFR, median [IQ], mm 0.88 [0.82-0.93] 0.84 [0.80-0.86] 0.95 [0.92-0.97] < 0.01
FFR = fractional flow reserve of the myocardium; PCI = percutaneous coronary intervention; RD = reference diameter; MLD = minimum 
luminal diameter.
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The functional significance of the lesion, measured 
by pre-PCI FFR, was the same in both groups (0.61 [0.49 
to 0.69] vs. 0.57 [0.46 to 0.69], P = 0.63). Figure 1 
presents the median [IQ] FFR after PCI when the treated 
vessel was the LAD, as compared with other vessels. It 
can be clearly observed that the median values of FFR 
after PCI in the LAD were significantly lower than those 
measured in other vessels (0.84 vs. 0.93; P < 0.01).
When the variables whose statistical tests showed 
significant differences were inserted between the two 
groups in the multivariate logistic regression analysis 
model, it was observed that only treatment of LAD 
showed to be an independent predictor of FFR < 0.90 
after PCI (Table 3 and Figure 2). The treatment of this 
vessel showed a 12-fold increased risk to obtain post-
PCI FFR < 0.90 compared to the other coronary arteries 
(OR = 11.9, 95% CI: 6.4 to 23.2, P < 0.01). Regarding 
the vessels which, after treatment, had FFR < 0.90, in 
approximately 79% of all cases the lesion was located 
in the LAD artery; conversely, of all lesions treated in 
the LAD, 84% produced post-PCI FFR < 0.90 (Figure 
3), and in over 75% of cases this FFR was due to the 
presence of diffuse atherosclerotic disease found along 
the vessel, according to the results obtained by the 
guide wire withdrawal curve after PCI. Moreover, in 
23% of lesions treated in the LAD (33/140 lesions), the 
post-PCI FFR was < 0.80, thus, this vessel still showed 
signs of myocardial ischemia despite the fact that 
the angiographically visible lesions had already been 
approached by PCI.
DISCUSSION
The results of this study confirm that treatment of 
the LAD is an important predictor of post-percutaneous 
coronary intervention FFR < 0.90, which may have prog-
nostic significance. The other clinical and angiographic 
variables analyzed were not independent predictors 
after the multivariate analysis.
TABLE 3  
Odds ratio (OR) for flow fractional reserve  
of the myocardium post-percutaneous coronary 
intervention (PCI) < 0.90 with a 95%  
confidence interval (95% CI)
OR 95% CI P-value
Left anterior 
descending artery 
11.9 6.4-23.2 < 0.01
Number of stents per 
lesion
0.08 0.3-2.3 0.69
Mean stent diameter 0,7 0.3-1.4 0.32
Pre-PCI RD 0.3 0.03-2.9 0.33
Pre-PCI MLD 15.8 0.08-329 0.30
pre-PCI % stenosis 57.2 0.08-752 0.56
Post-PCI RD 0.7 0.07-7.8 0.81
Post-PCI MLD 0.8 0.08-8.4 0.89
RD = reference diameter; MLD = minimum luminal diameter.
Figure 1 – Distribution of fractional flow reserve infarction (FFR) after 
stent implantation, when treating the left anterior descending artery 
(LAD) vs. other vessels. It is observed that the median FFR after stent 
implantation in ADA is significantly lower than in other coronary 
arteries (0.84 vs. 0.93; P < 0.01).
Figure 2 – Odds ratio (OR) determined by multivariate logistic regres-
sion analysis. Observe that only the treatment of the left anterior 
descending artery (LAD) is a significant independent predictor of a 
post-percutaneous coronary intervention (PCI) fractional flow reserve 
(FFR) < 0.90 (OR = 12.1, 95% CI: 6.5 to 23.4, P < 0.01). 
MLD = minimum lumen diameter; RD = reference diameter.
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A multicenter study coordinated by Pijls et al.,10 
involving 750 elective patients treated with PCI with bare-
metal stent (BMS) and followed for six months showed 
an overall event major adverse cardiac event (MACE) 
rate of 10.2%. However, when the patients were divided 
according with the post-stent FFR, it was observed that 
those whose FFR was ≥ 0.90 had MACE rates of only 
6.2%, whereas in those with post-stent FFR < 0.90, the 
MACE rate was 20.3 % (P < 0.001). In 6% of patients, 
post-stent FFR was < 0.80 and, in these patients, the 
rate of events was as high as 29.5%. In other words, 
the higher the FFR after stent implantation, the lower 
the rate of late-onset events and vice-versa. A less than 
ideal post-stent FFR can be briefly explained in three 
ways: (1) suboptimal stent implantation not detected by 
angiography, which could be recognized and corrected 
with the use of intracoronary ultrasonography; (2) the 
presence of a persistent gradient along the segment 
treated by stenting indicates abnormal flow pattern in 
that place, with low and heterogeneous shear stress, 
which may favor the process of restenosis despite the 
good anatomical result;13 and (3) FFR measurement 
after PCI not only indicates abnormalities in the treated 
area, but also throughout the remainder of the vessel.14 
Although not detectable by angiography or even by 
ultrasound, diffuse disease may be responsible for the 
higher rate of events in the FFR < 0.90 group. 
The present study raises the possibility that a 
suboptimal FFR after PCI (< 0.90) is a consequence 
of the approach of vessels with diffuse atherosclerotic 
disease, and indicates LAD as the most common site 
of occurrence of this abnormal physiological pattern. 
Unfortunately, the angiographic appearance of the vessel 
does not always allow for the inference of the presence 
of this disease, as previously demonstrated.14,15
The advent of drug-eluting stents used in the 
FAME 1 and 2 studies8,9 decreased the importance of 
FFR measurement after PCI, as the rate of late-onset 
adverse cardiac events with the use of these stents is 
very low. Still, no data are available regarding FFR after 
drug-eluting stent (DES) implantation and its impact on 
clinical outcomes of treated patients, comparing those in 
whom FFR normalized to those who still showed some 
residual ischemia. Additionally, DES use is not a reality 
in Brazil, in which the majority of patients submitted to 
PCI receive bare-metal stents, the only type subsidized 
by the Brazilian Unified Health System (Sistema Único 
de Saúde – SUS). Records from the Hospital Information 
System of SUS (SIH/SUS)16 demonstrate that in 2008, 
approximately 47,000 hospitalizations occurred through 
SUS for percutaneous coronary intervention, and that 
this number has tended to increase.
In this context, the present study is of great im-
portance, as the measurement of FFR after PCI was 
able to identify patients in whom the physiological 
post-PCI outcome was not adequate and which should 
be clinically monitored more closely, with the use of 
the available therapy arsenal aiming to minimize the 
risk of late events.
There are some limitations to this study: first, it 
was a retrospective, nonrandomized study, and patient 
clinical follow-up was not performed. However, the 
purpose of the study was to identify variables predictive 
of myocardial ischemia post-PCI, and not to evaluate 
the clinical outcome of these patients. Thus, this study 
is more apt to generate hypotheses to be investigated 
than to draw clinical conclusions and recommend 
conduct. Secondly, DES were not used in the treated 
population, which decreases, as previously mentioned, 
the importance of physiological assessment after PCI. As 
90% of PCI procedures performed in Brazil use BMS, 
the authors believe that the present study adequately 
reflects, in this respect, the clinical practice of this 
institution.
CONCLUSIONS
This study showed that the only clinical or angio-
graphic variable that can adequately predict myocar-
dial FFR after stent implantation of the treated vessel. 
Treatment of the left anterior descending artery was 
associated with a post-PCI myocardial FFR < 0.90 in 
most cases, which could result in an unfavorable clinical 
evolution in this group of patients; this finding should 
be adequately investigated in future clinical trials.
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